Transcription factor Gfi-1 induced by G-CSF is a negative regulator of CXCR4 in myeloid cells.
暂无分享,去创建一个
Peter J McCormick | Giovanna Tosato | M. de la Luz Sierra | Jinfang Zhu | G. Tosato | Jinfang Zhu | Maria De La Luz Sierra | Paola Gasperini | P. Gasperini | P. McCormick
[1] T. Nagasawa,et al. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. , 2006, Immunity.
[2] M. de la Luz Sierra,et al. G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells. , 2006, Blood.
[3] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[4] Tong-Yuan Yang,et al. The Gfi-1B Proto-Oncoprotein Repressesp21WAF1 and Inhibits Myeloid Cell Differentiation , 1998, Molecular and Cellular Biology.
[5] K. Zsebo,et al. In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[6] D. Link,et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. , 2005, Blood.
[7] A. Usheva,et al. Carboxyl-terminal Src kinase homologous kinase negatively regulates the chemokine receptor CXCR4 through YY1 and impairs CXCR4/CXCL12 (SDF-1alpha)-mediated breast cancer cell migration. , 2005, Cancer research.
[8] Hui Zeng,et al. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1 , 2002, Nature Genetics.
[9] Dennis C. Sgroi,et al. Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.
[10] T. Nakahata,et al. Exclusive expression of G‐CSF receptor on myeloid progenitors in bone marrow CD34+ cells , 2000, British journal of haematology.
[11] A. V. Gulino. WHIM syndrome: a genetic disorder of leukocyte trafficking , 2003, Current opinion in allergy and clinical immunology.
[12] L. Druhan,et al. Novel mechanism of G-CSF refractoriness in patients with severe congenital neutropenia. , 2005, Blood.
[13] J. Lévesque,et al. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. , 2003, The Journal of clinical investigation.
[14] J. Cowell,et al. Cloning and characterization of the TATA-less promoter from the human GFI1 proto-oncogene. , 2000, Annals of human genetics.
[15] Fan Dong,et al. Increased CCAAT Enhancer-binding Protein ϵ (C/EBPϵ) Expression and Premature Apoptosis in Myeloid Cells Expressing Gfi-1 N382S Mutant Associated with Severe Congenital Neutropenia* , 2006, Journal of Biological Chemistry.
[16] T. Möröy,et al. The Transcriptional Repressor Gfi1 Affects Development of Early, Uncommitted c-Kit+ T Cell Progenitors and CD4/CD8 Lineage Decision in the Thymus , 2003, The Journal of experimental medicine.
[17] D. Link,et al. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. , 1996, Immunity.
[18] J. Sodroski,et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.
[19] S. Arber,et al. ERM is required for transcriptional control of the spermatogonial stem cell niche , 2005, Nature.
[20] Booki Min,et al. Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation. , 2002, Immunity.
[21] S. Holly,et al. The unique N-terminus of R-ras is required for Rac activation and precise regulation of cell migration. , 2005, Molecular biology of the cell.
[22] T. Betsuyaku,et al. Characterization of hematopoietic progenitor mobilization in protease-deficient mice. , 2004, Blood.
[23] Y. Gazitt,et al. Plasma Levels of SDF‐1 and Expression of SDF‐1 Receptor on CD34+ Cells in Mobilized Peripheral Blood of Non‐Hodgkin's Lymphoma Patients , 2001, Stem cells.
[24] S. Orkin,et al. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells , 2004, Nature.
[25] Takashi Nagasawa,et al. Cellular niches controlling B lymphocyte behavior within bone marrow during development. , 2004, Immunity.
[26] A R Dunn,et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. , 1994, Blood.
[27] Scott Cameron,et al. Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. , 2003, Immunity.
[28] A. Fauci,et al. USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry. , 1999, Journal of immunology.
[29] H. Moch,et al. Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL , 2003, Nature.
[30] T. Springer,et al. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. , 1999, Immunity.
[31] R. Gorlin,et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease , 2003, Nature Genetics.
[32] P. Farnham,et al. Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. , 2002, Methods.
[33] D. Zhuang,et al. Increased CCAAT enhancer-binding protein epsilon (C/EBPepsilon) expression and premature apoptosis in myeloid cells expressing Gfi-1 N382S mutant associated with severe congenital neutropenia. , 2006, The Journal of biological chemistry.
[34] H. Nakshatri,et al. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion , 2007, Oncogene.
[35] D. Leduc,et al. Leukocyte Elastase Negatively Regulates Stromal Cell-derived Factor-1 (SDF-1)/CXCR4 Binding and Functions by Amino-terminal Processing of SDF-1 and CXCR4* , 2002, The Journal of Biological Chemistry.
[36] Zhijun Duan,et al. Targets of the transcriptional repressor oncoprotein Gfi-1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[37] George Eliopoulos,et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2 , 2003, Nature Genetics.
[38] C. Overall,et al. Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1* , 2001, The Journal of Biological Chemistry.
[39] Fred Schaper,et al. The zinc finger protein Gfi‐1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3 , 2000, The EMBO journal.
[40] D. Scadden,et al. CXCR-4 Desensitization Is Associated with Tissue Localization of Hemopoietic Progenitor Cells1 , 2001, The Journal of Immunology.
[41] M. Freedman,et al. Novel Point Mutation in the Extracellular Domain of the Granulocyte Colony-Stimulating Factor (G-Csf) Receptor in a Case of Severe Congenital Neutropenia Hyporesponsive to G-Csf Treatment , 1999, The Journal of experimental medicine.
[42] R. Taichman,et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4 , 2002, Nature Immunology.
[43] Hui Zeng,et al. Transcription factor Gfi1 regulates self‐renewal and engraftment of hematopoietic stem cells , 2004, The EMBO journal.
[44] H. Nakshatri,et al. NF-κ B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4* , 2003, Journal of Biological Chemistry.
[45] Edward J. Fuchs,et al. Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers , 2000, Antimicrobial Agents and Chemotherapy.
[46] D. Link,et al. G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. , 2002, Immunity.
[47] I. Touw,et al. Multiple Signals Mediate Proliferation, Differentiation, and Survival from the Granulocyte Colony-stimulating Factor Receptor in Myeloid 32D Cells* , 1999, The Journal of Biological Chemistry.
[48] D. Link,et al. STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. , 2001, Immunity.
[49] M. Parmentier,et al. Genomic organization and promoter characterization of human CXCR4 gene 1 , 1998, FEBS letters.
[50] D. Tweardy,et al. Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. , 1987, Journal of immunology.
[51] Lei Yao,et al. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. , 2002, Blood.
[52] S. Orkin,et al. Zinc-finger transcription factor Gfi-1: versatile regulator of lymphocytes, neutrophils and hematopoietic stem cells , 2006, Current opinion in hematology.
[53] R. Paroni,et al. Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus. , 1999, Blood.
[54] S. Rankin,et al. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. , 2003, Immunity.
[55] R. DePinho,et al. STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. , 2002, Immunity.
[56] Ari Elson,et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells , 2006, Nature Medicine.